A simple gesture could end an unnecessary risk. The Teofarma laboratory and the ANSM announced the reminder of the Lot 24005T of the Buccal spray Natispray 0.15 mg/dose after finding a manufacturing defect: “Some bottles may present leaks or even be empty “. The concern seems to come from a “defect in crimping certain bottles, at the time of their production “.
A manufacturing defect
The Natispray 0.15 mg/dose lot 24005T lot, a solution for oral spray, is targeted. It has expired on 06/2027, and has been distributed in pharmacies and hospitals since October 2, 2024. The recall follows the discovery of a defect in the setting, likely to cause leaks or empty bottles.
How do I know if I am concerned?
Simply check the lot number on the box or on the bottle. If it’s the 24005T, your bottle enters the recall. If in doubt, report it in pharmacies: a pharmacist can check the lot for you.
What if my bottle is the batch concerned?
Due to a risk of leakage of the product, go to pharmacy: your bottle will be exchanged for another lot. The laboratory ensures that stocks are sufficient to overcome this lot.
In the event of persistent chest pain for more than five minutes, despite two sprays spaced three minutes apart, or in the event of worsening despite the use of Natispray, Immediately call the Samu.